Abramson Cancer Center At Penn Medicine
Clinical trials sponsored by Abramson Cancer Center At Penn Medicine, explained in plain language.
-
Pill vs. shot: which blood thinner do bladder cancer patients prefer after surgery?
Disease control CompletedThis trial compared two blood thinners—apixaban (a pill) and enoxaparin (a shot)—in 126 bladder cancer patients after bladder removal surgery. The goal was to see which one patients were more likely to take as prescribed, which they preferred, and what it cost them. Participants …
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Blood test may shield cancer Patients' hearts from chemo damage
Disease control CompletedThis study looked at whether using a blood test (NTproBNP) to guide heart-protecting medications can safely prevent heart damage in people with breast cancer or lymphoma receiving anthracycline chemotherapy. About 108 adults participated, and researchers measured how many joined,…
Phase: PHASE1, PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Promising drug shows hope for Hard-to-Treat prostate cancer
Disease control CompletedThis study tested a drug called niraparib in 11 men with advanced prostate cancer that was no longer responding to hormone therapy but had recently been treated with platinum chemotherapy. The goal was to see if niraparib could keep the cancer from growing for at least 6 months. …
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New study tests best ways to help high-risk smokers kick the habit
Disease control CompletedThis study compared four different smoking cessation programs to see which one works best for underserved smokers who are getting lung cancer screening. Over 3,200 participants from four U.S. health systems took part. The goal was to help them quit smoking for at least six months…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Triple threat: new drug cocktail targets BRCA breast cancer
Disease control CompletedThis early-phase trial tested a combination of three drugs—olaparib, palbociclib, and fulvestrant—in 9 people with BRCA-mutated, hormone-positive, HER2-negative metastatic breast cancer. The main goal was to see if the combination is safe. Researchers also looked at how long the …
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Proton beam therapy tested for rare spine and skull base tumors
Disease control CompletedThis study tested proton beam therapy in 54 adults with chordomas or chondrosarcomas, rare tumors of the skull base and spine. The goal was to see if this precise radiation approach is feasible and safe, and to track both short- and long-term side effects. Researchers monitored h…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Radiation plus two immunotherapy drugs shows promise in advanced cancers
Disease control CompletedThis early-phase trial tested a new way to treat advanced cancers that have spread. It combined a special type of radiation with two immunotherapy drugs (MEDI4736 and tremelimumab) to see if the combination is safe and tolerable. The study included 53 adults with advanced melanom…
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Immunotherapy after standard care may delay lung cancer return
Disease control CompletedThis study tested whether the immunotherapy drug pembrolizumab (Keytruda) can help people with oligometastatic non-small cell lung cancer (NSCLC) who have already completed curative treatment. Fifty-one participants received pembrolizumab every three weeks for up to 16 cycles. Th…
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Heart shield for chemo: carvedilol may protect breast cancer Patients' hearts
Disease control CompletedThis early-phase study tested whether the heart medication carvedilol could safely protect breast cancer patients from heart damage caused by chemotherapy drugs like doxorubicin and trastuzumab. 68 women with early-stage breast cancer were assigned to either receive carvedilol or…
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Tweaking PET scans could sharpen lung cancer detection
Diagnosis CompletedThis study tested whether changing how FDG PET/CT scans are taken and processed can make them more accurate for staging lung cancer. Thirty adults with non-small cell lung cancer were enrolled. The goal was to see if better imaging could help doctors determine if cancer has sprea…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
LGBTQ+ teens get custom Anti-Vaping ads on social media – will it work?
Prevention CompletedThis study tested whether anti-vaping social media messages designed specifically for sexual and gender minority (SGM) teens could prevent them from starting to vape. Over 1,100 SGM youth aged 13-20 who had never vaped received either tailored or non-tailored messages. The goal w…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
New behavioral therapy shows promise for smoking cessation in HIV patients
Symptom relief CompletedThis study tested a new type of counseling called behavioral activation problem solving (BAPS) against standard smoking cessation counseling for people with HIV in Botswana. 651 participants were split into two groups to see which approach helped more people quit smoking. The goa…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Virtual reality offers calm before the radiation storm
Symptom relief CompletedThis pilot study tested whether a 10-minute virtual reality mindfulness program could help cancer patients relax before their radiation simulation. 25 adults scheduled for radiation planning used a VR headset to practice breathing exercises in a calming virtual environment. The m…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Texts and nudges may help more people get cancer genetic testing
Knowledge-focused CompletedThis study tested three types of messages to encourage genetic testing in 1,283 people at risk for hereditary breast and ovarian cancer. Participants received an electronic health record message, then a text message, then a doctor's reminder if needed. The goal was to see which a…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can the right words boost HPV vaccination? new study tests message strategies
Knowledge-focused CompletedThis completed study tested different messages to see which ones make adults more willing to get the HPV vaccine, which prevents certain cancers. Over 5,300 adults aged 18-45 were randomly assigned to read one of five theory-based messages or a control message. The goal was to fi…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Walking for a cause: study tests if games and charity boost family fitness
Knowledge-focused CompletedThis study tested whether social incentives like gamification and charity donations can help low-income families increase their physical activity. Nearly 800 participants from the Philadelphia area wore Fitbits and formed family teams. Each week, a random family member's step goa…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Free rides and scheduling help may boost lung cancer screening rates
Knowledge-focused CompletedThis completed study tested whether offering free transportation and help scheduling appointments could improve attendance at lung cancer screenings in Philadelphia. Over 250 residents with upcoming or missed low-dose CT scans were offered these services. The goal was to see if s…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Can a simple survey improve End-of-Life conversations for cancer patients?
Knowledge-focused CompletedThis pilot study tested whether a short survey can help hospitalized patients with advanced lung or gastrointestinal cancers discuss their goals and preferences with their oncologist after leaving the hospital. The survey asks about treatment goals and understanding of the diseas…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Does pack color change how you smoke? new study investigates
Knowledge-focused CompletedThis study tested whether the color of a cigarette package changes how much people smoke, how much harm they are exposed to, and how risky they think the cigarettes are. Over 200 smokers used low-nicotine cigarettes in different colored packs (gray, red, blue, or plain) for 30 da…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Peer ambassadors may boost clinical trial enrollment in gynecologic cancer
Knowledge-focused CompletedThis study tested whether a peer ambassador program could help more gynecologic cancer patients learn about and join clinical trials. Twenty-three patients with advanced or recurrent gynecologic cancer were paired with a mentor who had personal experience with cancer and clinical…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
AI and navigators team up to boost colon cancer screening in poor neighborhoods
Knowledge-focused CompletedThis study tested whether a program that uses computer algorithms to identify people who are overdue for colorectal cancer screening, combined with a patient navigator to help them schedule and complete the test, could increase screening rates. The study included 385 adults livin…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Robot steadies heads in real time, paving way for sharper brain radiation
Knowledge-focused CompletedThis study tested a non-invasive robotic platform that uses motion-tracking cameras to keep a person's head steady in real time. Twenty healthy volunteers took part to see how well the system could limit head movement. The goal is to use this device during brain radiation therapy…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Heart risks during CAR T-Cell therapy under the microscope
Knowledge-focused CompletedThis study followed 44 adults with leukemia or lymphoma who received CAR T-cell therapy to see how their hearts were affected. Researchers used heart scans, blood tests, and quality-of-life surveys before and after treatment. The goal was to learn how often heart problems occur a…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Which radiation is safer for the heart? new study compares proton and photon therapy in breast cancer patients.
Knowledge-focused CompletedThis study looked at 172 breast cancer patients to see how proton radiation compares to standard photon radiation in terms of heart health. Researchers measured heart function and blood markers before, during, and up to one year after treatment. The goal was to understand which t…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Healthy volunteers help sharpen cancer blood test
Knowledge-focused CompletedThis study collected blood from 43 healthy adults aged 18-60 to serve as a control group for a test that detects circulating tumor cells in cancer patients. Volunteers provided about 20 mL of blood at up to 20 different times. The goal is to make the cancer detection test more ac…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New tool helps seniors with low health literacy make smarter cancer screening choices
Knowledge-focused CompletedThis study tested a decision aid to help adults aged 76-85 with low health literacy decide about colorectal cancer screening. 60 participants from community health centers used the tool to weigh the benefits and risks. The goal was to see if it helped them make more informed scre…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Nudge study aims to boost MRI use for dense breast cancer detection
Knowledge-focused CompletedThis study looked at whether sending reminders (nudges) to doctors or patients could increase the number of women with extremely dense breasts who get a breast MRI. Over 1,300 women aged 40-74 took part. The goal was to see if these nudges work better for Black or White women.
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Nudges and alerts boost symptom tracking in cancer care
Knowledge-focused CompletedThis study looked at whether sending reminders to cancer patients and alerts to their nurses helps them complete regular symptom questionnaires. Over 476 patients starting a new cancer therapy were split into three groups: usual care, reminders plus nurse alerts during clinic vis…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Chatbot 'Penny' aims to reconnect cancer survivors with life-saving follow-up care
Knowledge-focused CompletedThis study tested a chatbot named Penny that sends text messages to help adult survivors of childhood or young adult cancers schedule follow-up appointments, lab work, and scans. The goal was to see if survivors who had not been to a clinic in over three years would use the chatb…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Can a simple nudge make chemo safer? new study explores
Knowledge-focused CompletedThis study looked at how to encourage doctors and patients to use DPYD testing before chemotherapy for gastrointestinal cancers. DPYD testing can identify people at higher risk of severe side effects from common chemo drugs. Researchers tested different messages and approaches wi…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New PET scan tracks immune response in melanoma patients
Knowledge-focused CompletedThis early-phase trial tested a special PET/CT imaging agent, Zirconium Zr 89 Crefmirlimab Berdoxam, to see if it can measure immune activity in tumors of patients with advanced melanoma. Six adults on immunotherapy plus hydroxychloroquine received scans before and after starting…
Phase: EARLY_PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 26, 2026 19:20 UTC
-
Free transport boosts lung cancer screening attendance in west philadelphia
Knowledge-focused CompletedThis study tested a community support program that offered free transportation to lung cancer screening appointments for West Philadelphia residents. Out of 242 participants, researchers measured how many people attended their scheduled low-dose CT scans. The goal was to see if r…
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:04 UTC